8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2007 / Randomized controlled trial
Twenty-nine individuals with ischaemic heart disease and glucose intolerance or type 2 diabetes were randomized to a Palaeolithic diet or a Consensus (Mediterranean-like) diet for 12 weeks. Over 12 weeks, AUC Glucose(0-120) decreased by 26% (p = 0.0001) in the Palaeolithic group and by 7% (p = 0.08) in the Consensus group. The larger improvement in the Palaeolithic group (p = 0.001) was independent of change in waist circumference (p = 0.0008). In the whole study population, change in AUC Glucose(0-120) showed no relationship with changes in weight or waist circumference.
Lindeberg S, Jönsson T, Granfeldt Y, et al. Diabetologia, 2007. PMID 17583796
2007 / Randomized crossover trial
In a randomized crossover trial, 20 adults with type 2 diabetes consumed 37 +/- 4 g/day of Salba or wheat bran for 12 weeks. Compared with wheat bran, Salba reduced systolic blood pressure by 6.3 +/- 4 mmHg (P < 0.001), high-sensitivity C-reactive protein by 40 +/- 1.6% (P = 0.04), and vonWillebrand factor by 21 +/- 0.3% (P = 0.03). Body weight and kidney function remained unchanged.
Vuksan V, Whitham D, Sievenpiper JL, et al. Diabetes Care, 2007. PMID 17686832
2007 / Randomized crossover trial
Seven lean healthy male volunteers underwent three oral glucose tolerance tests (OGTT) supplemented with 5 g placebo, 5 g cinnamon, or 5 g cinnamon taken 12 hours prior, using a randomized-crossover design. Cinnamon ingestion significantly reduced total plasma glucose response AUC compared to control by -13% when taken with the OGTT (p < 0.05) and by -10% when taken 12 hours prior (p < 0.05). Insulin sensitivity based on Matsuda's model was also significantly improved in both cinnamon trials compared with control (p < 0.05).
Solomon TP, Blannin AK Diabetes Obes Metab, 2007. PMID 17924872
2006 / Randomized controlled trial
Ninety-one obese patients were randomized to four groups taking treatments three times daily before meals for 12 weeks: placebo capsules plus apple juice, grapefruit capsules plus apple juice, grapefruit juice plus placebo capsules, or half a fresh grapefruit plus placebo capsules. After 12 weeks, weight loss was 1.6 kg with fresh grapefruit, 1.5 kg with grapefruit juice, 1.1 kg with grapefruit capsules, and 0.3 kg with placebo, with fresh grapefruit showing significantly more weight loss than placebo (P < .05). Among patients with metabolic syndrome, weight loss was significantly greater across all three grapefruit groups compared to placebo (P < .02). Fresh grapefruit also significantly reduced 2-hour post-glucose insulin levels compared with placebo.
Fujioka K, Greenway F, Sheard J, et al. J Med Food, 2006. PMID 16579728
2006 / Randomized crossover trial
Seven overweight or obese non-diabetic subjects ingested emulsions predominantly containing MUFA, PUFA, SFA, or water control at regular intervals for 24 hours in a random crossover design. Following 24 hours of ingestion, plasma NEFAs increased approximately 1.5- to 2-fold above basal for all fat emulsions, and all three reduced insulin clearance. SFA ingestion reduced insulin sensitivity, and insulin secretion failed to compensate for the insulin resistance. PUFA ingestion was associated with an absolute reduction in glucose-stimulated insulin secretion.
Xiao C, Giacca A, Carpentier A, et al. Diabetologia, 2006. PMID 16596361
2006 / Randomized clinical trial
Ninety-nine individuals with type 2 diabetes were randomly assigned to a low-fat vegan diet (n = 49) or an ADA guidelines diet (n = 50) for 22 weeks. Excluding participants who changed medications, HbA1c fell 1.23 points in the vegan group compared with 0.38 points in the ADA group (P = 0.01). Body weight decreased 6.5 kg in the vegan group compared with 3.1 kg in the ADA group (P < 0.001). Among those not changing lipid-lowering medications, LDL cholesterol fell 21.2% in the vegan group and 10.7% in the ADA group (P = 0.02), and urinary albumin reductions were also greater in the vegan group (15.9 mg/24 h vs. 10.9 mg/24 h, P = 0.013).
Barnard ND, Cohen J, Jenkins DJ, et al. Diabetes Care, 2006. PMID 16873779
2006 / Randomized double-blind placebo-controlled intervention trial
A randomized double-blind placebo-controlled trial evaluated oral standard nicotinamide (1.2 g/m2) versus placebo for 5 years in 40 first-degree relatives of patients with type 1 diabetes. Frequencies of type 1 diabetes development were similar between the intervention and placebo groups. End-of-study ICA frequencies, first-phase insulin release, and insulin sensitivity also showed no differences between groups, with no adverse events reported.
Cabrera-Rode E, Molina G, Arranz C, et al. Autoimmunity, 2006. PMID 16891222
2006 / Prospective analysis of randomized trial arm
Analyzing 1,079 adults across 3.2 years of an intensive lifestyle intervention, body weight reduction was the strongest predictor of lower diabetes incidence (hazard ratio 0.42 per 5-kg decrease, 95% CI 0.35-0.51; P < 0.0001). Each 1-kg reduction was linked to a 16% risk drop after adjusting for diet and activity. Among 495 participants missing initial weight loss goals, meeting exercise targets was associated with 44% lower incidence.
Hamman RF, Wing RR, Edelstein SL, et al. Diabetes Care, 2006. PMID 16936160
2006 / Controlled animal experiment and human genetic association study
Mice were treated with resveratrol to evaluate its effects on mitochondrial function and metabolic homeostasis, alongside an analysis of SIRT1 genetics in humans. Resveratrol treatment significantly increased aerobic capacity in mice, evidenced by higher running time and oxygen consumption in muscle fibers, and protected against diet-induced obesity and insulin resistance. The effects were associated with induction of genes for oxidative phosphorylation and mitochondrial biogenesis via PGC-1alpha and SIRT1 activation. Additionally, three Sirt1 SNPs were associated with energy homeostasis in Finnish subjects.
Lagouge M, Argmann C, Gerhart-Hines Z, et al. Cell, 2006. PMID 17112576
2006 / Clinical trial (acute meal test)
Fifteen healthy subjects consumed 2 control bread meals and 3 test meals: almonds and bread, parboiled rice, and instant mashed potatoes, balanced in macronutrients using butter and cheese. Glycemic indices for the rice (38 +/- 6) and almond meals (55 +/- 7) were significantly lower than for the potato meal (94 +/- 11) (P < 0.003), as were postprandial insulin AUCs (P < 0.001). Total antioxidant capacity showed no differences, but serum protein thiol concentrations increased after the almond meal (15 +/- 14 mmol/L) and decreased after the pooled control bread, rice, and potato meals (-10 +/- 8 mmol/L, P = 0.021).
Jenkins DJ, Kendall CW, Josse AR, et al. J Nutr, 2006. PMID 17116708
2006 / Randomized crossover trial
A randomized crossover study tested postprandial glucose responses to brown versus milled rice in 10 healthy and 9 type 2 diabetic volunteers. In healthy volunteers, brown rice produced a 19.8% lower glycemic area and 12.1% lower glycemic index (p < 0.05). In participants with diabetes, brown rice led to a 35.2% lower glycemic area and 35.6% lower glycemic index. In vitro starch testing showed 23.7% less sugar release from brown rice.
Panlasigui LN, Thompson LU Int J Food Sci Nutr, 2006. PMID 17127465
2005 / Randomized crossover trial
A randomized crossover study in 10 healthy obese women tested 14 days of a regular meal frequency (6 meals daily) versus an irregular pattern (3 to 9 meals daily). Regular eating resulted in lower reported energy intake (P < 0.01), enhanced postprandial thermogenesis (P < 0.01), and lower fasting total and LDL cholesterol (P < 0.01 and P < 0.02, respectively). Peak postprandial insulin and insulin area under the curve were also significantly reduced.
Farshchi HR, Taylor MA, Macdonald IA Am J Clin Nutr, 2005. PMID 15640455
2005 / Crossover trial
Ten type 2 diabetic subjects consumed six traditional Sudanese carbohydrate-rich meals on six occasions separated by 1-week intervals. Significant overall differences were observed in incremental AUCs for both plasma glucose (P = 0.0092) and plasma insulin (P = 0.0001). Two-hour glucose values ranged from 8.7 +/- 2.4 for wheat pancakes to 11.4 +/- 2.7 for maize porridge. Millet porridge followed by wheat pancakes displayed significantly lower post-prandial glucose and insulin responses, while maize porridge induced higher responses.
Abdelgadir M, Abbas M, Järvi A, et al. Diabet Med, 2005. PMID 15660741
2005 / Randomized crossover trial
A randomized crossover study evaluated 10 women following two 14-day periods of consuming or omitting breakfast. Eating breakfast produced lower reported energy intake (P=0.001) and a lower postprandial insulin area under the curve (P<0.01) than omitting breakfast. Skipping breakfast was also associated with higher fasting total cholesterol (3.43 vs 3.14 mmol/L) and LDL cholesterol (1.82 vs 1.55 mmol/L; P=0.001), while resting energy expenditure did not differ.
Farshchi HR, Taylor MA, Macdonald IA Am J Clin Nutr, 2005. PMID 15699226
2005 / Interventional crossover trial
Ten obese women completed two 2-week isocaloric diet periods containing either 16% (low-fat) or 56% (high-fat) of energy as fat. Baseline liver fat averaged 10 +/- 7%; it decreased by 20 +/- 9% during the low-fat diet and increased by 35 +/- 21% during the high-fat diet (P = 0.042 for change between diets). Fasting serum insulin decreased from 70 +/- 41 pmol/liter at baseline to 60 +/- 24 pmol/liter after the low-fat diet and increased to 81 +/- 44 pmol/liter after the high-fat diet (P = 0.005 for change between diets). Serum lipids, free fatty acids, and intraabdominal and subcutaneous fat masses remained unchanged.
Westerbacka J, Lammi K, Häkkinen AM, et al. J Clin Endocrinol Metab, 2005. PMID 15741262
2005 / Repeated-measures clinical studies
In two repeated-measures studies, adults consumed potato test meals after overnight fasting to evaluate glycemic response. In Study 1 (10 adults), precooked Russet potatoes elicited a lower glucose area under the curve than day-cooked potatoes (P < .05), whereas precooking had no effect on white potatoes. In Study 2 (12 adults), potato glycemic index varied significantly by variety and preparation (P = .003), ranging from 56 for cold boiled red potatoes to 89 for hot boiled red potatoes.
Fernandes G, Velangi A, Wolever TM J Am Diet Assoc, 2005. PMID 15800557
2005 / Randomized controlled trial
A randomized pilot trial assigned 242 newborn infants with HLA susceptibility and a first-degree relative with type 1 diabetes to receive casein hydrolysate or conventional cow's milk formula until 6 to 8 months of age. Over a mean 4.7-year follow-up, cumulative autoantibody emergence was somewhat lower with hydrolysed formula. Adjusted life-table analysis indicated significant protection against islet cell antibodies (P = 0.02) and at least one autoantibody (P = 0.03).
Akerblom HK, Virtanen SM, Ilonen J, et al. Diabetologia, 2005. PMID 15838685
2005 / Interventional trial with pre- and post-biopsies
Ten insulin-sensitive males were fed an isoenergetic high-fat diet (HFD) for 3 days, with muscle biopsies analyzed via oligonucleotide microarray. The HFD differentially regulated 297 genes, including decreasing six genes involved in oxidative phosphorylation (NDUFB3, NDUFB5, NDUFS1, NDUFV1, SDHB, and SLC25A12). Furthermore, PGC1alpha and PGC1beta mRNA levels decreased by -20% (P < 0.01) and -25% (P < 0.01), respectively. In mice fed a HFD for 3 weeks, similar OXPHOS and PGC1 mRNAs decreased by approximately 90%, and cytochrome C and PGC1alpha protein by approximately 40%.
Sparks LM, Xie H, Koza RA, et al. Diabetes, 2005. PMID 15983191
2005 / Randomized crossover trial
In a randomized crossover trial of 12 healthy adults, adding vinegar (18, 23, or 28 mmol acetic acid) to white wheat bread lowered postprandial blood glucose and insulin responses in an inverse dose-response pattern. Satiety ratings increased linearly with higher acetic acid doses. The highest vinegar dose significantly lowered 90-minute incremental areas for glycemic and insulinemic indices, though 120-minute values did not differ from reference bread.
Ostman E, Granfeldt Y, Persson L, et al. Eur J Clin Nutr, 2005. PMID 16015276
2005 / Randomized crossover trial
Thirteen healthy volunteers consumed four potato-based breakfast meals in random order to evaluate the effects of cold storage and vinegar addition. Chilling boiled potatoes for 24 hours increased resistant starch from 3.3% to 5.2% and lowered the insulin index by 28%. Adding vinaigrette to cold potatoes decreased the glycemic and insulinemic indices by 43% and 31%, respectively, relative to freshly boiled potatoes (glycemic index 96 vs 168; insulin index 128 vs 185).
Leeman M, Ostman E, Björck I Eur J Clin Nutr, 2005. PMID 16034360
2005 / Randomized controlled trial
In an outpatient setting, 64 overweight, postmenopausal women were randomly assigned to a low-fat, vegan diet or an NCEP-based control diet without energy limits for 14 weeks while maintaining exercise. The intervention group's body weight decreased by 5.8 +/- 3.2 kg compared with 3.8 +/- 2.8 kg in the control group (P = .012). An index of insulin sensitivity increased from 4.6 +/- 2.9 to 5.7 +/- 3.9 (P = .017) in the intervention group, but the between-group difference was not significant (P = .17).
Barnard ND, Scialli AR, Turner-McGrievy G, et al. Am J Med, 2005. PMID 16164885
2005 / Randomized crossover trial
Eleven healthy adults consumed a high-glycemic load meal or a lower-glycemic load meal alongside vinegar, peanut products, or control treatments in a crossover protocol. Vinegar and peanuts reduced 60-minute postprandial glucose responses by approximately 55%, reaching statistical significance for the high-glycemic load option. Later energy intake for the day dropped by roughly 200 to 275 kcal after the high-glycemic load meal, though this difference was not statistically significant (P = .111).
Johnston CS, Buller AJ J Am Diet Assoc, 2005. PMID 16321601
2004 / Randomized double-blind placebo-controlled trial
In a randomized double-blind placebo-controlled trial across Europe, Canada, and the USA, 552 relatives of individuals with type 1 diabetes received oral modified release nicotinamide (1.2 g/m2) or placebo for 5 years. Over the trial, 159 participants developed diabetes (82 taking nicotinamide and 77 on placebo). The unadjusted hazard ratio was 1.07 (95% CI 0.78-1.45; p=0.69), and the adjusted hazard ratio was 1.01 (95% CI 0.73-1.38; p=0.97). Nicotinamide also did not affect growth in children, first-phase insulin secretion, or rates of serious adverse events.
Gale EA, Bingley PJ, Emmett CL, et al. Lancet, 2004. PMID 15043959
2004 / Randomized crossover trial
In a randomized crossover trial of nine healthy lean women, participants consumed their normal diet either regularly across six daily meals or irregularly with three to nine daily meals for 14 days each. While fasting glucose and insulin were unchanged, peak insulin and insulin area under the curve after a test meal were higher with irregular eating (P < 0.01). Fasting total cholesterol (P < 0.01) and LDL cholesterol (P < 0.05) were also significantly higher following the irregular meal pattern.
Farshchi HR, Taylor MA, Macdonald IA Eur J Clin Nutr, 2004. PMID 15220950